Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded on January 6, 2015 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Turn Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Turn Therapeutics Inc. market cap is $142.36M.
What is the 52-week high for Turn Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Turn Therapeutics Inc. 52 week high is $26.50 as of October 25, 2025.
What is the 52-week low for Turn Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Turn Therapeutics Inc. 52 week low is $4.07 as of October 25, 2025.
What is the PE ratio of Turn Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Turn Therapeutics Inc.’s P/E ratio is -38.37.
What is the Price-to-Book ratio of Turn Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Turn Therapeutics Inc. P/B ratio is 29.3896.
What is the 50-day moving average of Turn Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Turn Therapeutics Inc. 50-day moving average is $5.83.
